Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Renouf

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Annals of Surgery|February 27, 2023
Circulating Tumor DNA as a Prognostic Factor in Patients With Resectable Hepatic Metastases of Uveal MelanomaPascale Mariani, François-Clément Bidard, Aurore Rampanou, et al.
Cancer Research|August 3, 2021
Unraveling Ewing Sarcoma Tumorigenesis Originating from Patient-Derived Mesenchymal Stem CellsAnna Sole, Sandrine Grossetête, Maxime Heintzé, et al.
Scientific Reports|August 18, 2023
Atezolizumab and paclitaxel as first line therapy in advanced triple-negative breast cancer patients included in the French early access programAlexandre de Moura, Perrine Vuagnat, Benjamin Renouf, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Annals of Surgery|February 27, 2023
Circulating Tumor DNA as a Prognostic Factor in Patients With Resectable Hepatic Metastases of Uveal MelanomaPascale Mariani, François-Clément Bidard, Aurore Rampanou, et al.
Cancer Research|August 3, 2021
Unraveling Ewing Sarcoma Tumorigenesis Originating from Patient-Derived Mesenchymal Stem CellsAnna Sole, Sandrine Grossetête, Maxime Heintzé, et al.
Scientific Reports|August 18, 2023
Atezolizumab and paclitaxel as first line therapy in advanced triple-negative breast cancer patients included in the French early access programAlexandre de Moura, Perrine Vuagnat, Benjamin Renouf, et al.
Pageof 2